psychiatry
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18–65 years, any sex. 2. Diagnosed by a psychiatrist according to DSM-5 or ICD-10/ICD-11 with a severe mental disorder (e.g., schizophrenia spectrum disorders, schizoaffective disorder, bipolar disorder with psychotic features, or major depressive disorder with psychotic features), currently in a community-based rehabilitation phase and clinically stable outpatient. 3. Clinically stable for at least 4 weeks: no acute exacerbation or hospitalization; no substantial changes to antipsychotic regimen (no change of agent and dose variation =80% of sessions; ITAQ indicates basic insight/treatment attitude, or can complete procedures with caregiver support. 6. Residual psychiatric symptoms at baseline to allow measurement of change: PANSS total and subscale scores consistent with mild-to-moderate severity. 7. Written informed consent obtained; if decision-making capacity is limited, consent from a legal guardian is required. 8. Living within the study community with no plan to relocate during the intervention and follow-up.
Exclusion criteria
Exclusion criteria: 1. Acute or unstable clinical status: within the past 4 weeks has marked agitation, high risk of self-harm or violence, or requires urgent medication adjustment/hospitalization; deemed unsuitable for group intervention by the treating psychiatrist. 2. Moderate-to-severe substance use disorder within the past 3 months (alcohol or illicit drugs), or current use of illicit substances that impair cognition/behavior. 3. Significant cognitive impairment or neurological disease (e.g., severe dementia, uncontrolled epilepsy) preventing understanding of instructions or completion of assessments. 4. Severe comorbid physical conditions posing risk during activities (e.g., uncontrolled cardiovascular disease, severe respiratory illness) or severe visual/hearing impairment that precludes participation in arts-based activities. 5. Electroconvulsive therapy (ECT) within the past month or planned ECT during the intervention. 6. Concurrent participation in other structured psychosocial interventions or other clinical trials that may confound outcome assessment. 7. Known allergy or contact dermatitis to art materials (e.g., paints, adhesives) that cannot be managed with safe alternatives. 8. Investigator’s judgment of very poor adherence, making completion of follow-up and scale assessments unlikely.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive and Negative Syndrome Scale (PANSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Life Satisfaction Index (LSI);Social Deficit Syndrome Scale (SDSS);Insight and Treatment Attitude Questionnaire (ITAQ);Medical Rehabilitation Status Scale (MRSS); | — |
Countries
Cina
Contacts
Dalian Seventh People's Hospital